[go: up one dir, main page]

WO1999031098A8 - Nouveaux derives de pyridine et de pyrimidine - Google Patents

Nouveaux derives de pyridine et de pyrimidine

Info

Publication number
WO1999031098A8
WO1999031098A8 PCT/DK1998/000549 DK9800549W WO9931098A8 WO 1999031098 A8 WO1999031098 A8 WO 1999031098A8 DK 9800549 W DK9800549 W DK 9800549W WO 9931098 A8 WO9931098 A8 WO 9931098A8
Authority
WO
WIPO (PCT)
Prior art keywords
pyrimidine derivatives
novel pyridine
prevention
treatment
derivatives
Prior art date
Application number
PCT/DK1998/000549
Other languages
English (en)
Other versions
WO1999031098A1 (fr
Inventor
Lars Jacob Stray Knutsen
Anker G Lundemose
Claus Bekker Jeppesen
Anders Robert Soerensen
Gillian Mary Danielsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to AU15562/99A priority Critical patent/AU1556299A/en
Publication of WO1999031098A1 publication Critical patent/WO1999031098A1/fr
Publication of WO1999031098A8 publication Critical patent/WO1999031098A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouvelle catégorie de dérivés substitués de pyridine et de pyrimidine, procédés servant à les préparer, compositions pharmaceutiques les contenant et leur utilisation pour le traitement et/ou la prévention de maladies nécessitant une diminution du glucose sanguin en tant que facteur de guérison. Ces dérivés sont particulièrement utiles pour le traitement et/ou la prévention du diabète sucré non insulino-dépendant (NIDDM).
PCT/DK1998/000549 1997-12-17 1998-12-11 Nouveaux derives de pyridine et de pyrimidine WO1999031098A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15562/99A AU1556299A (en) 1997-12-17 1998-12-11 Novel pyridine and pyrimidine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK1479/97 1997-12-17
DK147997 1997-12-17

Publications (2)

Publication Number Publication Date
WO1999031098A1 WO1999031098A1 (fr) 1999-06-24
WO1999031098A8 true WO1999031098A8 (fr) 1999-08-26

Family

ID=8105276

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1998/000549 WO1999031098A1 (fr) 1997-12-17 1998-12-11 Nouveaux derives de pyridine et de pyrimidine

Country Status (3)

Country Link
AU (1) AU1556299A (fr)
WO (1) WO1999031098A1 (fr)
ZA (1) ZA9811565B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320992B2 (en) * 2003-08-25 2008-01-22 Amgen Inc. Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use

Also Published As

Publication number Publication date
ZA9811565B (en) 1999-06-17
AU1556299A (en) 1999-07-05
WO1999031098A1 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
AU1923088A (en) Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
AU649605B2 (en) Retinal, derivatives and their therapeutic use
WO2000015211A3 (fr) Compositions et traitements contre les troubles du metabolisme du glucose
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU2002327430A1 (en) Methods for treating diabetes and other blood sugar disorders
WO2001090091A8 (fr) Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
HK1046527A1 (zh) 金剛烷衍生物
AU3028897A (en) New guanidine derivatives, methods of preparing them, and their use as drugs
WO2003028715A3 (fr) Nouvelle methode for d'inhibition de l'angiogenese
AU5015396A (en) Thiazole and thiadiazole derivatives, their preparation and pharmaceutical compositions useful in the treatment of throm bocytopenia
EP0825197A3 (fr) Nouveaux dérivés 6-hydroxy et 6-oxo-androstanes cardioactifs et compositions pharmaceutiques les renfermant
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
EP0327500A3 (fr) Dérivés de 1H-pyrazolo[3,4-b]pyridine substitués sur la position 5, leur préparation et compositions pharmaceutiques les contenant
AU7267091A (en) Derivatives of 4-(aminomethyl)piperidine, their preparation and their therapeutic application
HUP0302538A3 (en) 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
AU5980590A (en) 5-substituted 1,3,4-thiadizole derivatives, their preparation and their use as pesticides
WO2000057721A3 (fr) Solides comestibles utilises dans le traitement des troubles du metabolisme glucosique
WO1999042139A3 (fr) Conjugues d'amidon hydroxyethyle, leur procede de production et produits pharmaceutiques les contenant
AU5780398A (en) Pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy
AU2693697A (en) Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of medicaments intended for the normalization of the endothelial function, for the treatment of sexual dysfunction and vascular complications of diabetes, as well as vascular disorders of endothelial origin
WO2000078724A3 (fr) Composes pharmaceutiques
WO1999031098A8 (fr) Nouveaux derives de pyridine et de pyrimidine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA